신세포암종에서 Osteopontin 발현의 예후 인자로서 의의

참고문헌 (30)

1. "prognostic factorsrenal cell carcinoma: workgroup No.4. union internationale contre le cancer (UICC) and the american joint committee on cancer (AJCC)", 80, pp.994~996 (1997)
2. "Transformed mammalian cellssecrete specific proteins and phosphoproteins", 16, pp.885~93 (1979)
3. "Expression and distribution of osteopontin in human tissues:widespread association with luminal epithelial cell surfaces", 3, pp.1169~80 (1992)
4. "The role of osteopontin in tumor metastasis", 121, pp.228~241 (2004)
5. "Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer", 24, pp.6555~6563 (2005)
6. "NF-kappaB mediates alpha beta3 integrin-induced endothelial cell survival", 141, pp.1083~1093 (1998)
7. "Stimulation of endothelial cell migrationby vascular permeability factor", vascular endothelial growth factorthrough cooperative mechanisms involving the alpha beta3 integrin,osteopontin,and thrombin, 1996, pp.149, 293~305
8. "CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid,thereby stimulating cell motility and chemotaxis", 59, pp.219~226 (1999)
9. "Osteopontin-dependent CD44 6 expression and cell adhesion in HepG2 cells", 24, pp.1871~1878 (2003)
10. "Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer", 7, pp.4060~4060 (2001)
11. "Osteopontin expression and distribution in human carcinomas", 145, pp.610~623 (1994)
12. "Tumor-derived osteopontin is soluble,not matrix associated", 277, pp.9175~9182 (2002)
13. "Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies", 10, pp.184~190 (2004)
14. "Renal cell carcinoma in South Korea:a multicenter study", 35, pp.1556~1563 (2004)
15. "Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways", 94, pp.861~866 (1997)
16. "Induction of expression of osteopontin", pp.43~7
17. "Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell", 15, pp.476~487 (1995)
18. "HIF-1alpha-mediated up-regulation of vascular endothelial growth factor,independent of basic fibroblast growth factor,is important in the switch to the angiogenic phenotype during early tumorigenesis", 61, pp.5731~5735 (2001)
19. "Tissue repair and the dynamics of the extracellular matrix", 36, pp.1031~1037 (2004)
20. "Osteopontin(Eta-1)and fibroblast growth factor-2 cross-talk in angiogenesis", 171, pp.1085~1093 (2003)
21. "Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth", 60, pp.4010~4015 (2000)
22. "Activated Ras induces a proangiogenic phenotype in primary endothelial cells", 23, pp.192~200 (2004)
23. "Rac regulates vascular endothelial growth factor stimulated motility", 8, pp.1~13 (2001)
24. "Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells", 18, pp.4237~4246 (1999)
25. "Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators", 383, pp.229~234 (2002)
26. "Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells", 276, pp.4492~4635 (2001)
27. "Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12", 24, pp.489~501 (2005)
28. "Cancer and bone", 19, pp.18~54 (1998)
29. "Role of osteopontin in tumour progression", 90, pp.1877~1881 (2004)
30. "Novel murine mammary epithelial cell lines that form osteolytic bone metastases:effect of strain background on tumor homing", 20, pp.111~120 (2003)

관련 논문AI추천